Ciraparantag as a potential universal anticoagulant reversal agent

Eur Heart J. 2022 Mar 7;43(10):993-995. doi: 10.1093/eurheartj/ehab706.

Authors

Noel C Chan¹, Jeffrey I Weitz¹

Affiliation

¹ Thrombosis and Atherosclerosis Research Institute and McMaster University, Hamilton, Ontario, Canada.

PMID: 34648621
DOI: 10.1093/eurheartj/ehab706

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants* / therapeutic use
Anticoagulation Reversal*
Arginine / analogs & derivatives
Humans
Piperazines

Substances

Anticoagulants
Piperazines
Arginine
PER977